06 mar, 2018 - The FDA approval received in 2017 allows Grifols to market its Normal Saline solution in 500mL polypropylene bags in the U.S. to mitigate the current shortage of Normal Saline in this market
05 dec, 2017 - The European Investment Bank (EIB) and Grifols signed today an Euros 85 million loan to support the company's R+D+i initiatives focused on investigating new indications for plasma-derived protein therapies to treat rare and chronic diseases.
26 oct, 2017 - Grifols would like to make it clear that the rumours circulating regarding a possible sponsorship and stadium naming deal between F.C. Barcelona and the company are entirely unfounded. The company is not considering any sponsorship deal of this kind.
22 sep, 2017 - Prolastin®-C Liquid is the first liquid formulation of an alpha-1 antitrypsin deficiency replacement therapy manufactured in the U.S. The new formulation marks an important milestone in Grifols' ongoing R&D efforts